Home/Filings/4/0001213900-25-102676
4//SEC Filing

Leahy Emer 4

Accession 0001213900-25-102676

CIK 0001841330other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 5:26 PM ET

Size

5.7 KB

Accession

0001213900-25-102676

Insider Transaction Report

Form 4
Period: 2025-10-24
Leahy Emer
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-10-24+42,91342,913 total
    Exercise: $0.71Exp: 2035-10-23Common Stock (42,913 underlying)
Footnotes (1)
  • [F1]The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Documents

1 file

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

Related Parties

1
  • filerCIK 0001875180

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 5:26 PM ET
Size
5.7 KB